Science AMA Series: We are Drs. Brenda Moore and Todd Golde, neuroscientists at the University of Florida. Our findings reveal the potential for a drug therapy to be developed that could one day stop the progression of Alzheimer’s. Ask Us Anything!


See the source article by following the link below:

Hello Reddit, I am Brenda Moore, Ph.D., a neuroscientist in Dr. Todd Golde’s lab at the University of Florida. We conduct disease-oriented research with a focus on Alzheimer’s and other neurodegenerative diseases. And I am Todd Golde, M.D., Ph.D., director of the Evelyn F. and William L. McKnight Brain Institute at UF, where I oversee, champion and facilitate neuroscience and neuromedicine research programs across our campus. I am also director of the 1Florida Alzheimer’s Disease Research Center consortium of institutions.

We recently published a study featured on the cover of the Journal of Experimental Medicine titled Short Aβ peptides attenuate Aβ42 toxicity in vivo. Our research shows that short Abeta peptides were not toxic in two animal models — a mouse and a fruit fly — and in fact were protective from the toxic effects of Abeta 42. The accumulation of Abeta 42 in the brain is widely recognized as key in promoting Alzheimer’s disease. Our findings hold the potential for a drug therapy that could go beyond treating the symptoms of Alzheimer’s and target the disease’s progression.

To read our paper and news release, visit http://bit.ly/2nocJPI.

We will answer your questions at 1 pm EST ­— Ask Us Anything!

">Science AMA Series: We are Drs. Brenda Moore and Todd Golde, neuroscientists at the University of Florida. Our findings reveal the potential for a drug therapy to be developed that could one day stop the progression of Alzheimer’s. Ask Us Anything!

Science AMA series: Derek DuBois, MD. Founder of DOC (www.DOCjobs.com), prior partner at McKinsey and Accenture, here to talk about PhD and MD scientific careers beyond the academy and clinic, Ask Me Anything!


See the source article by following the link below:

I am Derek DuBois the founder of DOCjobs, the leading recruiting site specifically focused on careers in industry for people with advanced biomedical degrees. DOC started with a drinks meeting for 6 MDs from Columbia who had left traditional tracks and has since grown to 42,000 MD and PhD members pursuing careers in industry. I have experience in alternate and innovative careers for MDs/PhDs both through my own career as a partner at McKinsey and Accenture and through the 1,000 employers who have used DOC to recruit biomedical talent including investment banks/funds, biopharma, startups, consulting firms and others across the spectrum of healthcare.

MDs and PhDs face similar challenges in navigating to careers beyond the established academic/clinical/research tracks, while more and more are seeking such opportunities with the rise in physician burnout and the relative paucity of academic research positions.

AMA about applying your skills to careers in pharma/biotech, finance, consulting, and beyond.

My linkedin: https://www.linkedin.com/in/derek-d-dubois/

DOC: www.DOCjobs.com

">Science AMA series: Derek DuBois, MD. Founder of DOC (www.DOCjobs.com), prior partner at McKinsey and Accenture, here to talk about PhD and MD scientific careers beyond the academy and clinic, Ask Me Anything!